A detailed history of Us Bancorp \De\ transactions in Natera, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 9,411 shares of NTRA stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,411
Previous 12,661 25.67%
Holding current value
$1.58 Million
Previous $1.37 Million 12.76%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$97.75 - $129.67 $317,687 - $421,427
-3,250 Reduced 25.67%
9,411 $1.2 Million
Q2 2024

Aug 06, 2024

SELL
$85.28 - $112.6 $303,852 - $401,193
-3,563 Reduced 21.96%
12,661 $1.37 Million
Q1 2024

May 07, 2024

SELL
$59.21 - $92.9 $67,973 - $106,649
-1,148 Reduced 6.61%
16,224 $1.48 Million
Q4 2023

Feb 09, 2024

BUY
$37.55 - $62.64 $157,034 - $261,960
4,182 Added 31.71%
17,372 $1.09 Million
Q3 2023

Nov 03, 2023

SELL
$43.4 - $62.52 $20,181 - $29,071
-465 Reduced 3.41%
13,190 $583,000
Q2 2023

Aug 09, 2023

BUY
$47.08 - $55.16 $40,488 - $47,437
860 Added 6.72%
13,655 $664,000
Q1 2023

May 09, 2023

SELL
$36.57 - $58.29 $17,590 - $28,037
-481 Reduced 3.62%
12,795 $710,000
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $107,088 - $150,149
-3,134 Reduced 19.1%
13,276 $533,000
Q3 2022

Oct 27, 2022

SELL
$36.93 - $56.68 $29,359 - $45,060
-795 Reduced 4.62%
16,410 $720,000
Q2 2022

Aug 01, 2022

BUY
$28.13 - $44.54 $28,833 - $45,653
1,025 Added 6.33%
17,205 $610,000
Q1 2022

May 11, 2022

BUY
$30.32 - $91.33 $81,803 - $246,408
2,698 Added 20.01%
16,180 $658,000
Q4 2021

Feb 11, 2022

BUY
$86.26 - $119.0 $117,227 - $161,721
1,359 Added 11.21%
13,482 $1.26 Million
Q3 2021

Nov 10, 2021

BUY
$100.17 - $126.36 $45,377 - $57,241
453 Added 3.88%
12,123 $1.35 Million
Q2 2021

Aug 05, 2021

SELL
$86.05 - $119.72 $1.43 Million - $1.99 Million
-16,627 Reduced 58.76%
11,670 $1.33 Million
Q1 2021

Apr 28, 2021

BUY
$91.47 - $124.36 $625,563 - $850,498
6,839 Added 31.87%
28,297 $2.87 Million
Q4 2020

Feb 04, 2021

BUY
$66.66 - $111.74 $515,548 - $864,197
7,734 Added 56.35%
21,458 $2.14 Million
Q3 2020

Nov 10, 2020

BUY
$45.89 - $72.67 $506,304 - $801,768
11,033 Added 410.0%
13,724 $991,000
Q2 2020

Aug 07, 2020

BUY
$26.36 - $49.86 $18,452 - $34,902
700 Added 35.16%
2,691 $134,000
Q1 2020

May 13, 2020

BUY
$17.27 - $40.17 $8,289 - $19,281
480 Added 31.77%
1,991 $60,000
Q4 2019

Feb 04, 2020

BUY
$32.1 - $40.4 $21,571 - $27,148
672 Added 80.1%
1,511 $51,000
Q3 2019

Nov 08, 2019

SELL
$25.38 - $34.89 $57,358 - $78,851
-2,260 Reduced 72.93%
839 $28,000
Q2 2019

Aug 13, 2019

BUY
$17.75 - $27.58 $46,860 - $72,811
2,640 Added 575.16%
3,099 $86,000
Q1 2019

May 08, 2019

BUY
$11.34 - $20.62 $4,025 - $7,320
355 Added 341.35%
459 $9,000
Q3 2017

Nov 13, 2017

BUY
$8.02 - $13.33 $834 - $1,386
104
104 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.